Skip to main content

Venrock — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

156
Companies
$8.0B
Total invested
$54.9M
Avg. check
39
Industries
Health Care 9Biotechnology 8Software 8Artificial Intelligence (AI) 6Information Technology 5Therapeutics 5+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–120 of 156
GH Research
February 2025

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Biopharma · Dublin$150.0M Post Ipo Equity
Suki
January 2025

Suki provides AI-powered voice solutions that streamline healthcare documentation processes.

Artificial Intelligence (AI) · Redwood CitySeries Unknown
Oumi
January 2025

Oumi is a group of academics, developers dedicated to fostering greater transparency and cooperation in frontier AI.

Artificial Intelligence (AI) · Seattle$10.0M Seed
Astrix Security
December 2024

Astrix Security is a cloud-based security platform that protects non-human identities across SaaS, IaaS, and PaaS environments.

Artificial Intelligence (AI) · Tel Aviv$45.0M Series B
Simbe Robotics
October 2024

Simbe Robotics builds automation solutions for shelf auditing and analytics.

Artificial Intelligence (AI) · San Francisco$50.0M Series C
Scope3
October 2024

Scope3 is the source of truth for supply chain emissions data.

GreenTech · New York$25.0M Series B
Vanilla
August 2024

Vanilla is an estate planning software platform designed for financial advisors, estate planners, and family offices.

Artificial Intelligence (AI) · Salt Lake City$35.0M Series B
Tembo
July 2024

Tembo offers a platform that automates tasks for engineering teams, aiding them in coding and managing complexity effectively.

Artificial Intelligence (AI) · Cincinnati$14.0M Series A
Bright Peak Therapeutics
June 2024

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Biotechnology · Allschwil$90.0M Series C
ABL Space Systems
April 2024

ABL Space Systems specializes in building rockets to launch satellites.

Aerospace · El Segundo$20.0M Debt Financing
Applied Therapeutics
February 2024

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Biotechnology · New York$100.0M Post Ipo Equity
Gitar
February 2024

Gitar is a software development platform that builds end-to-end developer tooling to fix tech debt and deliver code.

Information Technology · San Mateo$9.0M Seed
Accompany Health
January 2024

Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions.

Health Care · Bethesda$56.0M Series A
Keros Therapeutics
January 2024

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Biotechnology · Lexington$140.0M Post Ipo Equity
MBrace Therapeutics
November 2023

MBrace Therapeutics is a privately held biopharmaceutical business.

Biotechnology · San Diego$85.0M Series B
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Ocelot Bio
July 2023

Ocelot Bio brings new treatment options to patients with severe liver disease.

Biotechnology · San Diego$3.0M Debt Financing
Running Tide
July 2023

The global ocean health company harnessing the power of ocean for a climate positive future.

CleanTech · Portland$250K Grant
Aeglea BioTherapeutics
June 2023

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Biotechnology · Austin$210.0M Post Ipo Equity
Airspeed
May 2023

Airspeed is a team-building platform for modern companies to connect digitally.

Information Services · Vancouver$5.0M Seed
Inscripta
January 2023

Inscripta is a life science technology company that develops digital genome engineering solutions.

Biotechnology · Pleasanton$4.4M Series Unknown
Mobile.dev
January 2023

mobile.dev is setting a new standard for mobile development, empowering all companies to deliver high-quality mobile applications.

Mobile Apps · San FranciscoSeed
Fygr
December 2022

Fygr is a cash management and forecasting solution service.

Finance · Paris$2.1M Series Unknown
Tricida
October 2022

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Health Care · Menlo Park$125.0M Post Ipo Debt

Where Venrock invests

Health Care9
Biotechnology8
Software8
Artificial Intelligence (AI)6
Information Technology5
Therapeutics5

About Venrock's portfolio

How many companies has Venrock invested in?▸

Venrock has invested in 156 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Venrock invest in?▸

Venrock's top investment sectors include Health Care, Biotechnology, Software, Artificial Intelligence (AI), Information Technology. The firm invests across 39 different industry categories.

What is Venrock's largest investment?▸

Among tracked funding rounds, Aeglea BioTherapeutics received $210.0M in a Post Ipo Equity round. Venrock's total known invested capital is $8.0B.

What is the average investment size for Venrock?▸

Venrock's average investment size is $54.9M across its portfolio of 156 companies.

What are Venrock's most recent investments?▸

Recent Venrock portfolio additions include GH Research, Suki, Oumi, Astrix Security, Simbe Robotics. These companies were founded in 2020 or later.

Reach the founders behind these 156 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →